Matthew Troyer — Vice President and Head of Early Clinical at Denali Therapeutics | Comparably
Denali Therapeutics is a biotechnology company read more
EMPLOYEE
PARTICIPANTS
6
TOTAL
RATINGS
68
Matthew Troyer — Vice President and Head of Early Clinical at Denali Therapeutics

Matthew Troyer — Vice President and Head of Early Clinical at Denali Therapeutics

Executive Bio

Matthew Troyer serves as the Vice President and Head of Early Clinical of Denali Therapeutics. Matthew started at Denali Therapeutics in December of 2018. Matthew currently resides in the San Francisco Bay Area.

Executive Team Culture Ratings from Denali Therapeutics Employees

TOP
50%
Denali Therapeutics' Executive Team scores in the Top 50%
of similar sized companies on Comparably
Who ranks the Executive Team the highest?
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Denali Therapeutics
Who ranks the Executive Team the lowest?
Not Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Denali Therapeutics

Denali Therapeutics' Executive Team at a Glance

Based on 4 ratings, Denali Therapeutics' employees are less satisfied with their Executive Team and give them a ā€œC+ā€ or 70/100.

Denali Therapeutics' Executive Team ranks in the Top 50% of other companies in San Francisco and Top 50% of other companies on Comparably that also have 51-200 Employees.

×
Rate your company